{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:16:21Z","timestamp":1794222981109,"version":"4.8.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Cancer Research Center (DKFZ), DKTK ED03"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2021,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Merkel cell carcinoma (MCC) is a highly invasive and metastatic skin cancer. While high expression of miR-375 is a characteristic of MCC, it seems not to contribute to the malignant phenotype of MCC cells. miR-375 enrichment in MCC-derived extracellular vesicles suggests its intercellular signaling function. Here, we demonstrate that horizontally transferred miR-375 causes fibroblast polarization toward cancer-associated fibroblasts (CAFs). The polarization is evidenced by phenotypic changes and induction of\n                    <jats:italic>\u03b1-SMA<\/jats:italic>\n                    ,\n                    <jats:italic>CXCL2<\/jats:italic>\n                    , and\n                    <jats:italic>IL-1\u03b2<\/jats:italic>\n                    . Fibroblast polarization is inhibited by specific antagomirs and mimicked by experimental miR-375 expression. Mechanistically, miR-375 downregulates\n                    <jats:italic>RBPJ<\/jats:italic>\n                    and\n                    <jats:italic>p53<\/jats:italic>\n                    , two key players regulating fibroblast polarization. In clinical MCC samples, in situ hybridization located miR-375 in CAFs, which correlated with high \u03b1-SMA protein and low\n                    <jats:italic>RBPJ<\/jats:italic>\n                    and\n                    <jats:italic>TP53<\/jats:italic>\n                    expression; single-cell RNAseq revealed a disparate fibroblast polarization negatively correlating with p53 pathway-related gene expression. Thus, the functional role of miR-375 in MCC is to generate a pro-tumorigenic microenvironment by inducing fibroblast polarization.\n                  <\/jats:p>","DOI":"10.1038\/s41388-020-01576-6","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T03:03:04Z","timestamp":1607655784000},"page":"980-996","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4310-4515","authenticated-orcid":false,"given":"Kaiji","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivelina","family":"Spassova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gravemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrin","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Gambichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"\u00d8dum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6931-8194","authenticated-orcid":false,"given":"David","family":"Schrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3524-7858","authenticated-orcid":false,"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Ugurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-653X","authenticated-orcid":false,"given":"J\u00fcrgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"1576_CR1","doi-asserted-by":"publisher","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","volume":"3","author":"JC Becker","year":"2017","unstructured":"Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbe C, Veness M, et al. Merkel cell carcinoma. Nat Rev Dis Prim. 2017;3:17077.","journal-title":"Nat Rev Dis Prim"},{"key":"1576_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.humpath.2018.09.003","volume":"84","author":"LO Wardhani","year":"2019","unstructured":"Wardhani LO, Matsushita M, Iwasaki T, Kuwamoto S, Nonaka D, Nagata K, et al. Expression of the IDO1\/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma. Hum Pathol. 2019;84:52\u201361.","journal-title":"Hum Pathol"},{"key":"1576_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1309\/AJCPIKDZM39CRPNC","volume":"142","author":"KG Paulson","year":"2014","unstructured":"Paulson KG, Iyer JG, Simonson WT, Blom A, Thibodeau RM, Schmidt M, et al. CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival a population-based study. Am J Clin Pathol. 2014;142:452\u20138.","journal-title":"Am J Clin Pathol"},{"key":"1576_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.humpath.2016.02.002","volume":"52","author":"NM Walsh","year":"2016","unstructured":"Walsh NM, Fleming KE, Hanly JG, Hache KD, Doucette S, Ferrara G, et al. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma. Hum Pathol. 2016;52:190\u20136.","journal-title":"Hum Pathol"},{"key":"1576_CR5","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/cancers6021047","volume":"6","author":"R Wheat","year":"2014","unstructured":"Wheat R, Roberts C, Waterboer T, Steele J, Marsden J, Steven NM, et al. Inflammatory cell distribution in primary Merkel cell carcinoma. Cancers. 2014;6:1047\u201364.","journal-title":"Cancers"},{"key":"1576_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"1576_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.addr.2015.07.007","volume":"99","author":"G Ishii","year":"2016","unstructured":"Ishii G, Ochiai A, Neri S. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. Adv Drug Deliv Rev. 2016;99:186\u201396.","journal-title":"Adv Drug Deliv Rev"},{"key":"1576_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/excr.1999.4543","volume":"250","author":"G Serini","year":"1999","unstructured":"Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res. 1999;250:273\u201383.","journal-title":"Exp Cell Res"},{"key":"1576_CR9","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ncb3399","volume":"18","author":"S Dror","year":"2016","unstructured":"Dror S, Sander L, Schwartz H, Sheinboim D, Barzilai A, Dishon Y, et al. Melanoma miRNA trafficking controls tumour primary niche formation. Nat Cell Biol. 2016;18:1006\u201317.","journal-title":"Nat Cell Biol"},{"key":"1576_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell. 2010;17:135\u201347.","journal-title":"Cancer Cell"},{"key":"1576_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0740-2","volume":"18","author":"KM Bussard","year":"2016","unstructured":"Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18:84.","journal-title":"Breast Cancer Res"},{"key":"1576_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou WP. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17:559\u201372.","journal-title":"Nat Rev Immunol"},{"key":"1576_CR13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.112.005983","volume":"64","author":"E van der Pol","year":"2012","unstructured":"van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharm Rev. 2012;64:676\u2013705.","journal-title":"Pharm Rev"},{"key":"1576_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255\u201389.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1576_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1146\/annurev-physiol-021014-071641","volume":"77","author":"S Kourembanas","year":"2015","unstructured":"Kourembanas S. Exosomes: vehicles of Intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol. 2015;77:13\u201327.","journal-title":"Annu Rev Physiol"},{"key":"1576_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","volume":"15","author":"R Xu","year":"2018","unstructured":"Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ. Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15:617\u201338.","journal-title":"Nat Rev Clin Oncol"},{"key":"1576_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654\u201372.","journal-title":"Nat Cell Biol"},{"key":"1576_CR18","doi-asserted-by":"publisher","first-page":"1278a","DOI":"10.1002\/hep.24504","volume":"54","author":"T Kogure","year":"2011","unstructured":"Kogure T, Yan IK, Lin WL, Patel T. Inter-cellular nanovesicle mediated microrna transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011;54:1278a\u20131279a.","journal-title":"Hepatology"},{"key":"1576_CR19","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1038\/onc.2014.300","volume":"34","author":"H Cui","year":"2015","unstructured":"Cui H, Seubert B, Stahl E, Dietz H, Reuning U, Moreno-Leon L, et al. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Oncogene. 2015;34:3640\u201350.","journal-title":"Oncogene"},{"key":"1576_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2015.10.011","volume":"370","author":"Y Liu","year":"2016","unstructured":"Liu Y, Luo F, Wang BR, Li HQ, Xu Y, Liu XL, et al. STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells. Cancer Lett. 2016;370:125\u201335.","journal-title":"Cancer Lett"},{"key":"1576_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","volume":"25","author":"W Zhou","year":"2014","unstructured":"Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25:501\u201315.","journal-title":"Cancer Cell"},{"key":"1576_CR22","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1158\/0008-5472.CAN-10-4455","volume":"71","author":"JL Hood","year":"2011","unstructured":"Hood JL, San RS, Wickline SA. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 2011;71:3792\u2013801.","journal-title":"Cancer Res"},{"key":"1576_CR23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.30607","volume":"70","author":"J Liu","year":"2019","unstructured":"Liu J, Fan L, Yu H, Zhang J, He Y, Feng D, et al. Endoplasmic reticulum stress causes liver cancer cells to release exosomal miR-23a-3p and up-regulate programmed death ligand 1 expression in macrophages. Hepatology. 2019;70:241\u201358.","journal-title":"Hepatology"},{"key":"1576_CR24","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/cas.12747","volume":"106","author":"W Pang","year":"2015","unstructured":"Pang W, Su J, Wang Y, Feng H, Dai X, Yuan Y, et al. Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts. Cancer Sci. 2015;106:1362\u20139.","journal-title":"Cancer Sci"},{"key":"1576_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02583-0","volume":"9","author":"T Fang","year":"2018","unstructured":"Fang T, Lv H, Lv G, Li T, Wang C, Han Q, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9:191.","journal-title":"Nat Commun"},{"key":"1576_CR26","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ajpath.2015.11.020","volume":"186","author":"KJ Abraham","year":"2016","unstructured":"Abraham KJ, Zhang X, Vidal R, Pare GC, Feilotter HE, Tron VA. Roles for miR-375 in neuroendocrine differentiation and tumor suppression via Notch pathway suppression in Merkel cell carcinoma. Am J Pathol. 2016;186:1025\u201335.","journal-title":"Am J Pathol"},{"key":"1576_CR27","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1158\/1078-0432.CCR-18-1184","volume":"24","author":"K Fan","year":"2018","unstructured":"Fan K, Ritter C, Nghiem P, Blom A, Verhaegen ME, Dlugosz A, et al. Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinoma. Clin Cancer Res. 2018;24:5873\u201382.","journal-title":"Clin Cancer Res"},{"key":"1576_CR28","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1172\/JCI68760","volume":"123","author":"N Renwick","year":"2013","unstructured":"Renwick N, Cekan P, Masry PA, McGeary SE, Miller JB, Hafner M, et al. Multicolor microRNA FISH effectively differentiates tumor types. J Clin Invest. 2013;123:2694\u2013702.","journal-title":"J Clin Invest"},{"key":"1576_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/jid.2013.355","volume":"134","author":"H Xie","year":"2014","unstructured":"Xie H, Lee L, Caramuta S, Hoog A, Browaldh N, Bjornhagen V, et al. MicroRNA expression patterns related to Merkel cell polyomavirus infection in human Merkel cell carcinoma. J Invest Dermatol. 2014;134:507\u201317.","journal-title":"J Invest Dermatol"},{"key":"1576_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jid.2019.06.135","volume":"140","author":"KJ Fan","year":"2020","unstructured":"Fan KJ, Gravemeyer J, Ritter C, Rasheed K, Gambichler T, Moens U, et al. MCPyV large T antigen-induced Atonal Homolog 1 Is a lineage-dependency oncogene in Merkel Cell Carcinoma. J Invest Dermatol. 2020;140:56\u201365.","journal-title":"J Invest Dermatol"},{"key":"1576_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.yexmp.2013.05.001","volume":"95","author":"J Hudson","year":"2013","unstructured":"Hudson J, Duncavage E, Tamburrino A, Salerno P, Xi L, Raffeld M, et al. Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma. Exp Mol Pathol. 2013;95:62\u201367.","journal-title":"Exp Mol Pathol"},{"key":"1576_CR32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1158\/1541-7786.MCR-10-0573","volume":"9","author":"J Szczyrba","year":"2011","unstructured":"Szczyrba J, Nolte E, Wach S, Kremmer E, Stohr R, Hartmann A, et al. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Mol Cancer Res. 2011;9:791\u2013800.","journal-title":"Mol Cancer Res"},{"key":"1576_CR33","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1158\/0008-5472.CAN-11-1020","volume":"71","author":"E Nishikawa","year":"2011","unstructured":"Nishikawa E, Osada H, Okazaki Y, Arima C, Tomida S, Tatematsu Y, et al. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res. 2011;71:6165\u201373.","journal-title":"Cancer Res"},{"key":"1576_CR34","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1073\/pnas.0810550106","volume":"106","author":"MN Poy","year":"2009","unstructured":"Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. P Natl Acad Sci USA. 2009;106:5813\u20138.","journal-title":"P Natl Acad Sci USA"},{"key":"1576_CR35","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.dnarep.2013.06.002","volume":"12","author":"Y Liu","year":"2013","unstructured":"Liu Y, Xing R, Zhang X, Dong W, Zhang J, Yan Z, et al. miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells. DNA Repair. 2013;12:741\u201350.","journal-title":"DNA Repair"},{"key":"1576_CR36","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/ijc.28563","volume":"135","author":"JW Yan","year":"2014","unstructured":"Yan JW, Lin JS, He XX. The emerging role of miR-375 in cancer. Int J Cancer. 2014;135:1011\u20138.","journal-title":"Int J Cancer"},{"key":"1576_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/cancers12030529","volume":"12","author":"K Fan","year":"2020","unstructured":"Fan K, Zebisch A, Horny K, Schrama D, Becker JC. Highly expressed miR-375 is not an intracellular oncogene in Merkel cell polyomavirus-associated Merkel cell carcinoma. Cancers. 2020;12:529.","journal-title":"Cancers"},{"key":"1576_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH 2nd, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189\u201396.","journal-title":"Science"},{"key":"1576_CR39","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno G, Soldatov R, Zeisel A, Braun E, Hochgerner H, Petukhov V, et al. RNA velocity of single cells. Nature. 2018;560:494\u20138.","journal-title":"Nature"},{"key":"1576_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.canlet.2018.02.002","volume":"420","author":"R Bhome","year":"2018","unstructured":"Bhome R, Del Vecchio F, Lee GH, Bullock MD, Primrose JN, Sayan AE, et al. Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer. Cancer Lett. 2018;420:228\u201335.","journal-title":"Cancer Lett"},{"key":"1576_CR41","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ncb2370","volume":"13","author":"M Prager-Khoutorsky","year":"2011","unstructured":"Prager-Khoutorsky M, Lichtenstein A, Krishnan R, Rajendran K, Mayo A, Kam Z, et al. Fibroblast polarization is a matrix-rigidity-dependent process controlled by focal adhesion mechanosensing. Nat Cell Biol. 2011;13:1457\u2013U1178.","journal-title":"Nat Cell Biol"},{"key":"1576_CR42","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1073\/pnas.1719076115","volume":"115","author":"S Arandkar","year":"2018","unstructured":"Arandkar S, Furth N, Elisha Y, Nataraj NB, van der Kuip H, Yarden Y, et al. Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features. Proc Natl Acad Sci USA. 2018;115:6410\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1576_CR43","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.celrep.2017.08.048","volume":"20","author":"S Goruppi","year":"2017","unstructured":"Goruppi S, Procopio MG, Jo S, Clocchiatti A, Neel V, Dotto GP. The ULK3 kinase is critical for convergent control of cancer-associated fibroblast activation by CSL and GLI. Cell Rep. 2017;20:2468\u201379.","journal-title":"Cell Rep."},{"key":"1576_CR44","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ncb3228","volume":"17","author":"MG Procopio","year":"2015","unstructured":"Procopio MG, Laszlo C, Al Labban D, Kim DE, Bordignon P, Jo SH, et al. Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nat Cell Biol. 2015;17:1193\u2013204.","journal-title":"Nat Cell Biol"},{"key":"1576_CR45","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1158\/2159-8290.CD-12-0206","volume":"2","author":"AK Mitra","year":"2012","unstructured":"Mitra AK, Zillhardt M, Hua YJ, Tiwari P, Murmann AE, Peter ME, et al. MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Disco. 2012;2:1100\u20138.","journal-title":"Cancer Disco"},{"key":"1576_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","volume":"20","author":"W Yan","year":"2018","unstructured":"Yan W, Wu XW, Zhou WY, Fong MY, Cao MH, Liu J, et al. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol. 2018;20:597\u2013609.","journal-title":"Nat Cell Biol"},{"key":"1576_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.trsl.2014.05.011","volume":"164","author":"V Thayanithy","year":"2014","unstructured":"Thayanithy V, Dickson EL, Steer C, Subramanian S, Lou E. Tumor-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes. Transl Res. 2014;164:359\u201365.","journal-title":"Transl Res"},{"key":"1576_CR48","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1002\/pmic.201600223","volume":"16","author":"A Konstantinell","year":"2016","unstructured":"Konstantinell A, Bruun JA, Olsen R, Aspar A, Skalko-Basnet N, Sveinbjornsson B, et al. Secretomic analysis of extracellular vesicles originating from polyomavirus-negative and polyomavirus-positive Merkel cell carcinoma cell lines. Proteomics. 2016;16:2587\u201391.","journal-title":"Proteomics"},{"key":"1576_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Disco. 2019;18:99\u2013115.","journal-title":"Nat Rev Drug Disco"},{"key":"1576_CR50","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.3389\/fimmu.2018.03053","volume":"9","author":"D Khare","year":"2018","unstructured":"Khare D, Or R, Resnick I, Barkatz C, Almogi-Hazan O, Avni B. Mesenchymal stromal cell-derived exosomes affect mRNA expression and function of B-lymphocytes. Front Immunol. 2018;9:3053.","journal-title":"Front Immunol"},{"key":"1576_CR51","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1242\/jcs.170373","volume":"129","author":"X Liang","year":"2016","unstructured":"Liang X, Zhang L, Wang S, Han Q, Zhao RC. Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. J Cell Sci. 2016;129:2182\u20139.","journal-title":"J Cell Sci"},{"key":"1576_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08989-2","volume":"10","author":"AC Frank","year":"2019","unstructured":"Frank AC, Ebersberger S, Fink AF, Lampe S, Weigert A, Schmid T, et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype. Nat Commun. 2019;10:1135.","journal-title":"Nat Commun"},{"key":"1576_CR53","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/bjh.15547","volume":"183","author":"AG Seto","year":"2018","unstructured":"Seto AG, Beatty X, Lynch JM, Hermreck M, Tetzlaff M, Duvic M, et al. Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma. Br J Haematol. 2018;183:428\u201344.","journal-title":"Br J Haematol"},{"key":"1576_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049.","journal-title":"Nat Commun"},{"key":"1576_CR55","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411\u201320.","journal-title":"Nat Biotechnol"},{"key":"1576_CR56","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"1576_CR57","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ijc.10321","volume":"99","author":"S Popp","year":"2002","unstructured":"Popp S, Waltering S, Herbst C, Moll I, Boukamp P. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer. 2002;99:352\u201360.","journal-title":"Int J Cancer"},{"key":"1576_CR58","doi-asserted-by":"publisher","first-page":"45730","DOI":"10.18632\/oncotarget.10160","volume":"7","author":"LM Lindahl","year":"2016","unstructured":"Lindahl LM, Fredholm S, Joseph C, Nielsen BS, Jonson L, Willerslev-Olsen A, et al. STAT5 induces miR-21 expression in cutaneous T cell lymphoma. Oncotarget. 2016;7:45730\u201344.","journal-title":"Oncotarget"},{"key":"1576_CR59","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1576_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01576-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01576-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01576-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:40:24Z","timestamp":1697316024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01576-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,2,4]]}},"alternative-id":["1576"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-01576-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,11]]},"assertion":[{"value":"18 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CR is now an employee of Merck Serono. Thilo Gambichler reports receiving speakers and\/or advisory board honoraria from BMS, Sanofi-Genzyme, MSD, Novartis Pharma, Roche, Abbvie, Almirall, Janssen, Lilly, Pfizer, Pierre-Fabre, MerckSerono, outside the submitted work. N\u00d8 has received advisory honoraria from Micreos and Zealand Pharma. DS has received honoraria from Bristol-Myers Squibb, Roche, Novartis, Regeneron, Sanofi, MerckSerono, Amgen, 4SC, Merck Sharp and Dohme, Array, Pierre Fabre, Philogen, Incyte, and Pfizer, and research funding from Bristol-Myers Squibb and Novartis. SU declares research support from Bristol Myers Squibb and MerckSerono; speakers and advisory board honoraria from Bristol Myers Squibb, Merck Sharp and Dohme, Merck Serono, Novartis and Roche, as well as travel support from Bristol Myers Squibb, Merck Sharp and Dohme. JCB has received speaker honoraria from Amgen, MerckSerono, Pfizer, and Sanofi advisory board honoraria from 4SC, Amgen, CureVac, eTheRNA, MerckSerono, Novartis and InProTher, as well as research funding from Alcedis, Boehringer Ingelheim, Bristol-Myers Squibb, IQVIA, and MerckSerono; he also received travel support from 4SC and Incyte. All other authors state no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}